Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Comparison of categoric clinical variables in monotherapy and stented groups
Monotherapy Group (n = 35) Stented Group (n = 33) P
No. % No. %
Sex 
    Male 14 40 11 33.3 .561
    Female 21 60 22 66.7
Prior thromboembolic event 
    Negative 31 88.6 32 97 .357
    Positive 4 11.4 1 3
Smoking 
    Negative 24 68.6 27 81.8 .267
    Positive 11 31.4 6 18.2
Hypertension 
    Negative 24 68.6 23 69.6 .920
    Positive 11 31.4 10 30.4
Diabetes mellitus 
    Negative 32 91.4 32 97 .614
    Positive 3 8.6 1 3
Hyperlipidemia 
    Negative 33 94.2 30 90.9 .668
    Positive 2 5.8 3 9.1
Malignancy 
    Negative 33 94.2 30 90.9 .668
    Positive 2 5.8 3 9.1

	Monotherapy Group (n = 35)		Stented Group (n = 33)		P
	No.	%	No.	%	P
Sex
Male	14	40	11	33.3	.561
Female	21	60	22	66.7	.561
Prior thromboembolic event
Negative	31	88.6	32	97	.357
Positive	4	11.4	1	3	.357
Smoking
Negative	24	68.6	27	81.8	.267
Positive	11	31.4	6	18.2	.267
Hypertension
Negative	24	68.6	23	69.6	.920
Positive	11	31.4	10	30.4	.920
Diabetes mellitus
Negative	32	91.4	32	97	.614
Positive	3	8.6	1	3	.614
Hyperlipidemia
Negative	33	94.2	30	90.9	.668
Positive	2	5.8	3	9.1	.668
Malignancy
Negative	33	94.2	30	90.9	.668
Positive	2	5.8	3	9.1	.668